Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows [Yahoo! Finance Canada]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance Canada
LONDON, Feb 13 (Reuters) - Hedge fund bets against Hims & Hers Health hit their highest in at ?least a year in January, just before the online telehealth ?firm clashed with Novo Nordisk over its cut-price weight-loss pill, according to data shared with ?Reuters by Hazeltree. Hims withdrew its low-cost pill earlier this month under scrutiny from the U.S. Food and Drug Administration, and was hit with fresh lawsuits from former partner Novo Nordisk - a sequence that wiped a third off its ?share price in less than ?a week. Nearly 65% of available Hims stock was loaned out for short selling last month, Hazeltree said - the most ?since October 2025, based on data from more than 600 asset managers tracking 16,000 global stocks. Short sellers borrow shares to bet their prices will fall. Hims ?did not ?immediately respond to an emailed request ?for comment. Its shares have fallen ?more than 50% since the start of 2026. Short interest reached a record high on February 12, according
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows [Yahoo! Finance]Yahoo! Finance
- Mixed options sentiment in Hims and Hers Health with shares down 2.18% [Yahoo! Finance]Yahoo! Finance
- Hims & Hers: Does Big Pharma Always Win? (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- Hims & Hers Health (NYSE:HIMS) was given a new $31.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.MarketBeat
- Hims & Hers Health: The GLP-1 Trade Just Got Real (Rating Downgrade) [Seeking Alpha]Seeking Alpha
HIMS
Earnings
- 11/3/25 - Miss
HIMS
Sec Filings
- 2/13/26 - Form SCHEDULE
- 2/4/26 - Form 4
- 1/21/26 - Form 4
- HIMS's page on the SEC website